Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy

Summary

RATIONALE: Everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase II trial is studying how well everolimus works in treating older patients with mantle cell lymphoma who received previous first-line or second-line chemotherapy.

Timeline

Start

2008-05

Primary completion

2011-05

Completion

2014-09

Outcome

Outcome not reported

Stopped: “Lack of participations (8 of 25)”

Drugs

Indications